A Misclassification Network-Based Method for Comparative Genomic Analysis

TL;DR

This paper introduces GMNA, a novel AI and network science-based framework for classifying genomes that improves understanding of misclassification drivers, demonstrated on SARS-CoV-2 data with implications for global health analysis.

Contribution

The study presents GMNA, a new flexible, network-based genomic classification method that incorporates misclassified instances and learned scoring to enhance interpretability and accuracy.

Findings

Successfully classified SARS-CoV-2 genomes by sampling location.

Revealed insights into how human mobility influences viral spread.

Demonstrated the framework's effectiveness with multiple AI models.

Abstract

Classifying genome sequences based on metadata has been an active area of research in comparative genomics for decades with many important applications across the life sciences. Established methods for classifying genomes can be broadly grouped into sequence alignment-based and alignment-free models. Conventional alignment-based models rely on genome similarity measures calculated based on local sequence alignments or consistent ordering among sequences. However, such methods are computationally expensive when dealing with large ensembles of even moderately sized genomes. In contrast, alignment-free (AF) approaches measure genome similarity based on summary statistics in an unsupervised setting and are efficient enough to analyze large datasets. However, both alignment-based and AF methods typically assume fixed scoring rubrics that lack the flexibility to assign varying importance to different parts of the sequences based on prior knowledge. In this study, we integrate AI and network science approaches to develop a comparative genomic analysis framework that addresses these limitations. Our approach, termed the Genome Misclassification Network Analysis (GMNA), simultaneously leverages misclassified instances, a learned scoring rubric, and label information to classify genomes based on associated metadata and better understand potential drivers of misclassification. We evaluate the utility of the GMNA using Naive Bayes and convolutional neural network models, supplemented by additional experiments with transformer-based models, to construct SARS-CoV-2 sampling location classifiers using over 500,000 viral genome sequences and study the resulting network of misclassifications. We demonstrate the global health potential of the GMNA by leveraging the SARS-CoV-2 genome misclassification networks to investigate the role human mobility played in structuring geographic clustering of SARS-CoV-2.